Oryzon Announces $1 Million Grant From Kabuki Syndrome Philanthropists to Support a Precision Medicine Phase I/II Trial With Vafidemstat
Stock Information for Acme United Corporation.
Loading
Please wait while we load your information from QuoteMedia.